We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current EQ market cap is 79.02M. The company's latest EPS is USD -1.7776 and P/E is -1.28.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 15.76M | 8.88M | 9.12M | 8.87M |
Operating Income | -13.24M | 2.04M | -4.11M | -3.59M | -3.62M |
Net Income | -13.66M | 2.77M | -3.94M | -3.34M | -3.71M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 15.76M |
Operating Income | -8.62M | -26.73M | -29.55M | -37.79M | -62.08M |
Net Income | -13.25M | -25.6M | -29.81M | -39.05M | -62.43M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 48.63M | 78.42M | 71.79M | 58.76M | 55.23M |
Total Liabilities | 20.47M | 46.48M | 42.52M | 31.78M | 31.12M |
Total Equity | 28.16M | 31.94M | 29.27M | 26.98M | 24.11M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 67.16M | 55.54M | 85.43M | 85.41M | 78.42M |
Total Liabilities | 2.23M | 13.69M | 15.57M | 18.9M | 46.48M |
Total Equity | 64.94M | 41.85M | 69.85M | 66.51M | 31.94M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -36.46M | -8.73M | -8M | -14.21M | -16.12M |
Investing | 11.71M | 18.68M | -25.18M | -10.18M | 804k |
Financing | 141k | -1.22M | -1.43M | -9.05M | -9.31M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -7.53M | -22.95M | -24.62M | -32.08M | -8.73M |
Investing | -37.43M | -2.17M | -18.59M | 27.41M | 18.68M |
Financing | 66.37M | 9.84M | 53.95M | 31.06M | -1.22M |
Market Cap | 79.02M |
Price to Earnings Ratio | -1.28 |
Price to Sales Ratio | 5.08 |
Price to Cash Ratio | 1.35 |
Price to Book Ratio | 2.51 |
Dividend Yield | - |
Shares Outstanding | 35.12M |
Average Volume (1 week) | 375.85k |
Average Volume (1 Month) | 255.53k |
52 Week Change | 214.69% |
52 Week High | 3.25 |
52 Week Low | 0.45 |
Spread (Intraday) | 0.18 (7.47%) |
Company Name | Equillium Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.equilliumbio.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions